Your session is about to expire
← Back to Search
Dual Task Training for Mild Cognitive Impairment
N/A
Recruiting
Led By Tanvi Bhatt
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No recent major surgery (< 6 months) or hospitalization (< 3 months)
Absence of any acute or chronic neurological (Stroke, Parkinson's disease, Alzheimer's disease), cardiopulmonary, musculoskeletal, or systemic diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (1st novel slip, trip week 1), immediate post-training (repeated perturbation training session, week 1) and 4 weeks of training
Awards & highlights
Study Summary
This trial will study whether a combined cognitive and perturbation training can help reduce falls in older adults with mild cognitive impairment.
Who is the study for?
This trial is for older adults over 55 with mild cognitive impairment (MOCA score <26). Participants must be able to walk unassisted for more than 10 meters, not use sedatives, have no recent major surgeries or hospitalizations, and can't have chronic neurological, cardiopulmonary, musculoskeletal diseases. They should understand English and meet certain heart rate and blood pressure criteria.Check my eligibility
What is being tested?
The study tests dual task perturbation training on a treadmill designed to improve balance and prevent falls in older adults with mild cognitive impairment. It aims to enhance coordination of limbs, muscle responses, balance control, and cognition through controlled disturbances during walking.See study design
What are the potential side effects?
While specific side effects are not listed for this type of physical intervention training, participants may experience fatigue or discomfort from the exercises. There's also a potential risk of falls during the training itself.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I haven't had major surgery or been hospitalized in the last 6 and 3 months, respectively.
Select...
I do not have any chronic conditions like stroke, Parkinson's, Alzheimer's, heart or lung issues.
Select...
I can walk more than 10 meters without help.
Select...
I am over 55 and my MOCA score indicates mild cognitive impairment or I am cognitively intact.
Select...
I am not taking any sedative medications.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (1st novel slip, trip week 1), immediate post-training (repeated perturbation training session, week 1) and 4 weeks of training
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (1st novel slip, trip week 1), immediate post-training (repeated perturbation training session, week 1) and 4 weeks of training
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Limb support gain or loss
Change in Stability gain or loss
Change in accuracy of Visual clock test
+12 moreSecondary outcome measures
Balance evaluation Systems test
Berg Balance scale
Change in physical activity level (Questionnaires)
+7 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Single session dual task perturbation training-OAwMCIExperimental Treatment1 Intervention
Participants will receive single session training of dual task. Six cognitive games that target working memory, executive functioning, visuomotor reactions, and language fluency will be provided in standing to get themselves familiarized. Following the cognitive tasks, participants will receive 12 slips without performing cognitive task (Single task training) at the highest intensity. Subsequently, 12 slips during standing while performing a cognitive task (dual task) will be administered. Similarly, they will then undergo 12 dual task walking trials (at self-selected speed) followed by 12 walking slips.
Group II: Multiple session dual task perturbation training-OAwMCIExperimental Treatment1 Intervention
All participants will undergo stance and walking perturbation training for 4 weeks. Six cognitive games that target working memory, executive functioning, visuomotor reactions, and language fluency will be provided in standing to get themselves familiarized. Following the cognitive tasks, participants will receive 12 slips without performing cognitive task (Single task training) at the highest intensity. Subsequently, 12 slips during standing while performing a cognitive task (dual task) will be administered. Similarly, they will then undergo 12 dual task walking trials (at self-selected speed) followed by 12 walking slips.
Group III: Single session dual task perturbation training-CIOAActive Control1 Intervention
All participants will receive only one training session of dual task. Six cognitive games that target working memory, executive functioning, visuomotor reactions, and language fluency will be provided in standing to get themselves familiarized. Following the cognitive tasks, participants will receive 12 slips without performing cognitive task (Single task training) at the highest intensity. Subsequently, 12 slips during standing while performing a cognitive task (dual task) will be administered. Similarly, they will then undergo 12 dual task walking trials (at self-selected speed) followed by 12 walking slips.
Find a Location
Who is running the clinical trial?
University of Illinois at ChicagoLead Sponsor
609 Previous Clinical Trials
1,559,167 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,676 Previous Clinical Trials
28,021,357 Total Patients Enrolled
Roybal Predoctoral pilot grantUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't had major surgery or been hospitalized in the last 6 and 3 months, respectively.I do not have any chronic conditions like stroke, Parkinson's, Alzheimer's, heart or lung issues.I can walk more than 10 meters without help.I haven't had any major surgeries or bone fractures in the last six months.My heart rate, blood pressure, and oxygen levels are within safe ranges.I am over 55 and my MOCA score indicates mild cognitive impairment or I am cognitively intact.I weigh more than 220 lbs.I have a pacemaker, metal implants (not for bones), or severe fear of tight spaces, or had cataract surgery with lenses not MRI-safe.I am not taking any sedative medications.
Research Study Groups:
This trial has the following groups:- Group 1: Single session dual task perturbation training-CIOA
- Group 2: Multiple session dual task perturbation training-OAwMCI
- Group 3: Single session dual task perturbation training-OAwMCI
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger